Evidence map›Paper›PMID 36555687›Full record

ArticleInternational journal of molecular sciences2022

The Arylamidine T-2307 as a Novel Treatment for the Prevention and Eradication of

Angela Maione, Alessandra La Pietra, Antonietta Siciliano, Aldo Mileo, Maria De Falco, Elisabetta de Alteriis, Marco Guida, Emilia Galdiero

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Pharmacological advances inJournal of enzyme inhibition and medicinal chemistry · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Angela MaioneDepartment of Biology, University of Naples 'Federico II', Via Cinthia, 80126 Naples, Italy.ORCID 0000-0002-4981-8837
Alessandra La PietraDepartment of Biology, University of Naples 'Federico II', Via Cinthia, 80126 Naples, Italy.ORCID 0000-0001-6108-9457
Antonietta SicilianoDepartment of Biology, University of Naples 'Federico II', Via Cinthia, 80126 Naples, Italy.ORCID 0000-0001-9041-9056
Aldo MileoDepartment of Biology, University of Naples 'Federico II', Via Cinthia, 80126 Naples, Italy.ORCID 0000-0002-1156-8107
Maria De FalcoDepartment of Biology, University of Naples 'Federico II', Via Cinthia, 80126 Naples, Italy.
Elisabetta de AlteriisDepartment of Biology, University of Naples 'Federico II', Via Cinthia, 80126 Naples, Italy.ORCID 0000-0002-5874-3961
Marco GuidaDepartment of Biology, University of Naples 'Federico II', Via Cinthia, 80126 Naples, Italy.ORCID 0000-0001-6805-0408
Emilia GaldieroDepartment of Biology, University of Naples 'Federico II', Via Cinthia, 80126 Naples, Italy.ORCID 0000-0001-8116-0839
University of Naples Federico II · ITIstituto Nazionale Biostrutture e Biosistemi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsCandidiasisAmidinesAnimalsBiofilmsCandida tropicalisHumansMaleMicrobial Sensitivity TestsAmidinesAntifungal AgentsT-2307antibiofilm activitybiofilmsCandida tropicaliscytokinesGalleria mellonellainvasive fungal infectionsin vitro susceptibility

Identifiers

PMID36555687
PMCPMC9786618
OpenAlexW4312210469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.